Integrating medicine, engineering and business to educate early-stage researchers in cardiovascular device development - Nature.com

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.
Advertisement
Career feature
Nature Biotechnology volume 40, pages 1528–1529 (2022)Cite this article
1 Altmetric
Metrics details
Developing a device development educational core will further enhance national, international and multidisciplinary innovation and collaboration in the biomedical device domain.
Academic researchers and physicians play a critical role in biomedical innovation, particularly in the field of medical devices¹. Collaborations between physicians/researchers and industry have led to such devices as steerable cardiac catheters and artificial heart valves¹. Now, more than ever, there is potential to treat and cure diseases with devices and technology.
This is a preview of subscription content, access via your institution

Subscribe to Nature+
Get immediate online access to the entire Nature family of 50+ journals
$29.99
monthly

Subscribe to Journal
Get full journal access for 1 year
$99.00
only $8.25 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
Sullivan, T. The significant physician contribution to the development of medical devices. Policy & Medicine (May); https://www.policymed.com/2013/10/the-significant-physician-contribution-to-the-development-of-medical-devices.html (2018).
Langin, K. Science https://doi.org/10.1126/science.caredit.aax3138 (2019).
Article PubMed Google Scholar
Xu, H., Gilliam, R. S. T., Peddada, S. D., Buchold, G. M. & Collins, T. R. L. Nat. Biotechnol. 36, 197–202 (2018).
CAS Article Google Scholar
Kahn, S. & Ginther, D. K. Nat. Biotechnol. 35, 90–94 (2017).
CAS Article Google Scholar
Fayolle, A. & Gailly, B. J. Small Bus. Manag. 53, 75–93 (2015).
Article Google Scholar
Niccum, B. A., Sarker, A., Wolf, S. J. & Trowbridge, M. J. Med. Educ. Online 22, 1360722 (2017).
Article Google Scholar
Anonymous. Why do 75% of U.S. based medical device start-ups fail? Proximo (July); https://proximomedical.com/why-do-75-of-u-s-based-medical-device-start-ups-fail/ (2019).
Anonymous. What is the medical device development process (includes stages). TWI; https://www.twi-global.com/technical-knowledge/faqs/what-is-the-medical-device-development-process (2022).
Anonymous. Cardiovascular devices market size is prognosticated to reach USD 86.27 billion by 2028, exhibiting a CAGR of 6.9%. Fortune Business Insights (September); https://www.globenewswire.com/en/news-release/2021/09/06/2291732/0/en/Cardiovascular-Devices-Market-Size-Is-Prognosticated-to-Reach-USD-86-27-Billion-by-2028-Exhibiting-a-CAGR-of-6-9.html (2021).
Elliott, C., Mavriplis, C. & Anis, H. Intl Entrep. Manag. J. 16, 43–67 (2020).
Article Google Scholar
International Society for Cardiovascular Translational Research. Translational Pathways for Cardiovascular Devices; https://isctr.org/online-course-translational-pathways-for-cardiovascular-devices/ (2021).
Zalaznick, M. Tech transfer: Ranking the top 25 research universities in the U.S. University Business (May); https://universitybusiness.com/tech-transfer-ranking-the-top-25-research-universities-heartland-forward/ (2022).
Download references
The authors received funding from the Biomedical Entrepreneurship Skills Development Program for the Advancement of Research Translation (DK 119114), the Clinical and Translational Science Award (TR001445) and the Short-Term Research Training Grant for Medical Students (DK007421).
New York University Grossman School of Medicine, New York, New York, USA
Gabriel Vizgan, Zachary Hill-Whilton, Colleen Gillespie, Daniel Cobos & Gabrielle Gold-von Simson
SUNY Downstate College of Medicine, Brooklyn, New York, USA
Gabriel Vizgan
International Society for Cardiovascular Translational Research, Phoenix, Arizona, USA
LeAnn Johnson & Nabil Dib
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
Correspondence to Gabriel Vizgan.
The authors declare no competing interests.
Reprints and Permissions
Vizgan, G., Hill-Whilton, Z., Gillespie, C. et al. Integrating medicine, engineering and business to educate early-stage researchers in cardiovascular device development. Nat Biotechnol 40, 1528–1529 (2022). https://doi.org/10.1038/s41587-022-01498-6
Download citation
Published: 07 October 2022
Issue Date: October 2022
DOI: https://doi.org/10.1038/s41587-022-01498-6
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Advertisement
Nature Biotechnology (Nat Biotechnol) ISSN 1546-1696 (online) ISSN 1087-0156 (print)
© 2022 Springer Nature Limited
Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.